Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 8,892 shares at $25.30 ($226K) on 2019-05-01, disclosed to the SEC on 2019-05-03.
Open-market sale of $226k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.30 | 3,892 | $98K | 43.6% |
| 2 | $25.30 | 3,892 | $98K | 43.6% |
| 3 | $26.01 | 1,108 | $29K | 12.8% |
| Total | $25.39 avg | 8,892 | $226K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |